Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

Company Overview - Myriad Genetics, Inc. is a leader in molecular diagnostic testing and precision medicine, focusing on advancing health and well-being for all [3] - The company develops molecular tests that assess disease risk and guide treatment decisions, aiming to improve patient care and reduce healthcare costs [3] Upcoming Events - Myriad management will participate in two healthcare conferences: the Wells Fargo Healthcare Conference on September 4 at 3:45 PM ET and the Morgan Stanley Annual Global Healthcare Conference on September 10 at 7:45 AM ET [1][4] - Live and archived webcasts of both presentations will be available at investor.myriad.com [2]